prostate cancer

Pfizer funnels $15M into 3-year ACS initiative designed to tackle cancer care disparities
Fierce Biotech
Mon, 02/5/24 - 10:23 am
Pfizer
American Cancer Society
clinical trials
pharma marketing
breast cancer
prostate cancer
CellVax receives FDA clearance for prostate cancer drug trial
Clinical Trials Arena
Tue, 01/30/24 - 10:47 am
CellVax Therapeutics
FDA
FK-PC101
prostate cancer
clinical trials
Point and Lantheus’s Radioligand Drug Shows Effectiveness, but Not Enough for Wall Street
BioSpace
Mon, 12/18/23 - 10:14 pm
Point Biopharma
Lantheus Holdings
radioligands
prostate cancer
Eli Lilly
Xtandi cleared by FDA for earlier-stage prostate cancer
Pharmaphorum
Fri, 11/17/23 - 10:10 am
Pfizer
Astellas
Xtandi
prostate cancer
FDA
Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff
Fierce Biotech
Thu, 11/16/23 - 11:45 am
Astellas
Propella Therapeutics
M&A
JNJ
Zytiga
prostate cancer
Novartis Builds Case for Earlier Prostate Cancer Treatment with Phase III Data
BioSpace
Tue, 10/24/23 - 09:54 am
ESMO
Novartis
prostate cancer
Pluvicto
radiopharmaceuticals
ESMO: Ambrx's 'reset' arrives at the last line of prostate cancer, offering the kind of safety rarely seen
Fierce Biotech
Mon, 10/23/23 - 10:33 am
ESMO
Ambrx
prostate cancer
ARX517
antibody-drug conjugate
EU clears review of Xtandi in earlier-stage prostate cancer
Pharmaphorum
Wed, 09/13/23 - 06:02 pm
EMA
Europe
Astellas
Pfizer
prostate cancer
Xtandi
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans
Reuters
Thu, 09/7/23 - 10:44 am
Astellas
Medicare
prostate cancer
Xtandi
drug pricing
Inflation Reduction Act
Exelixis and Ipsen to seek approval for Cabometyx in prostate cancer
Clinical Trials Arena
Mon, 08/21/23 - 10:02 am
Exelixis
Ipsen
Carbometyx
prostate cancer
Arcus and Gilead terminate development for etrumadenant in prostate cancer
Clinical Trials Arena
Tue, 08/8/23 - 10:36 pm
Arcus Biosciences
Gilead Sciences
prostate cancer
etrumadenant
Regeneron rethinks CD28 bispecific R&D plan after 2 patients die
Fierce Biotech
Thu, 08/3/23 - 10:17 am
Regeneron
prostate cancer
clinical trials
patient deaths
REGN5678
bispecific antibodies
Astellas to withhold prostate cancer drug from contract pharmacies
Beckers Hospital Review
Thu, 07/6/23 - 10:03 pm
Astellas
340B
Xtandi
prostate cancer
Sanofi blocks Sandoz's Jevtana generic in patent win
Fierce Pharma
Fri, 06/30/23 - 10:16 am
Sanofi
Jevtana
generics
Sandoz
prostate cancer
legal
Pfizer's Talzenna snags broader prostate cancer nod than AstraZeneca and Merck's rival PARP med
Fierce Pharma
Thu, 06/22/23 - 10:12 am
Pfizer
FDA
prostate cancer
Talzenna
AstraZeneca
PARP inhibitors
Merck
Clarity commences COMBAT theranostic prostate cancer trial in the US
Drugs.com
Wed, 06/21/23 - 10:36 am
Clarity Pharmaceuticals
clinical trials
radiopharmaceuticals
prostate cancer
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:53 am
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
This Startup Just Raised $90M To Fight Cancer
Crunchbase
Thu, 05/4/23 - 09:15 am
Convergent Therapeutics
funding
oncology
radiopharmaceuticals
prostate cancer
Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients
Seeking Alpha
Mon, 05/1/23 - 10:13 am
Pfizer
Astellas
Xtandi
prostate cancer
clinical trials
Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease
Fierce Biotech
Thu, 04/6/23 - 10:01 am
Immunic
prostate cancer
psoriasis
MS
multiple sclerosis
celiac disease

Pages